The clinical, cardiac, renal, arterial and neurohormonal effects of omapatrilat, a vasopeptidase inhibitor, in patients with chronic heart failure

Journal of the American College of Cardiology

Volumn 36, Issue 2, 2000, Pages 479-486

  McClean, Dougal R ^a   Ikram, Hamid ^a   Garlick, Amanda H ^a   Richards, A Mark ^a   Nicholls, M Gary ^a   Crozier, Ian G ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MEMBRANE METALLOENDOPEPTIDASE; OMAPATRILAT; PROTEINASE INHIBITOR;

ADRENALIN BLOOD LEVEL; ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VOLUME; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MEGADOSE; ENZYME INHIBITION; FEMALE; FUNCTIONAL ASSESSMENT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE WALL; HUMAN; MALE; MULTICENTER STUDY; NATRIURESIS; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SINUS RHYTHM; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; BLOOD VOLUME; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EPINEPHRINE; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY; MALE; METALLOENDOPEPTIDASES; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PYRIDINES; THIAZEPINES; VENTRICULAR FUNCTION, LEFT;

EID: 0033862042     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00741-5     Document Type: Article

References (41)

1. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
2. Effects of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
3. Role of endogenous atrial natriuretic factor in acute congestive heart failure
4. Hemodynamic, renal and endocrine effects of atrial natriuretic peptide infusion in severe heart failure
5. Hemodynamic effects of atrial peptide infusion in heart failure
6. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A
7. Cardiorenal and neurohumeral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors
8. Neutral endopeptidase 24.11 inhibition may not exhibit beneficial haemodynamic effects in patients with congestive heart failure
9. Chronic inhibition of endopeptidase 24.11 in essential hypertension: Evidence for enhanced atrial natriuretic peptide and angiotensin II
10. Dual metalloprotease inhibitors: Mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase
11. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure
12. Simultaneous inhibition of neutral endopeptidase and angiotensin converting enzyme by omapatrilat increased survival in heart failure hamsters greater than ACE inhibition (abstr)
13. Long-term beneficial hemodynamic and neurohormonal effects of vasopeptidase inhibition with omapatrilat in heart failure (abstr)
14. Effects of BMS-186716, a new dual metalloprotease inhibitor, on pharmacodynamic markers of neutral endopeptidase (NEP) and angiotensin converting enzyme (ACE) activity in healthy men (abstr)
15. Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography - A comparison of cineangiographic and radionuclide techniques
16. Pulsed Doppler echocardiographic determination of stroke volume and cardiac output: Clinical validation of two new methods using the apical window
17. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure
18. An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man
19. Wall stress and patterns of hypertrophy in the human left ventricle
20. Left ventricular end-systolic wall stress-velocity of fibre shortening relation: A load-independent index of myocardial contractility
21. A physiological approach to drug therapy in dilated cardiomyopathy
22. Radioimmunoassay and characterisation of atrial natriuretic peptide in human plasma
23. Assay of brain natriuretic peptide (BNP) in human plasma: Evidence for high molecular weight BNP as a major component in heart failure
24. Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man
25. Radioimmunoassay for cyclic nucleotides
26. A direct radioimmunoassay for aldosterone in plasma
27. Determination of plasma volume with indocyanine green in man
28. Determination of plasma volume and total blood volume using indocyanine green: a short review
29. Angiotensin inhibition potentiates the renal response to neutral endopeptidase inhibition in dogs with congestive heart failure
30. Effects of UK 69 578: A novel atriopeptidase inhibitor
31. Effect of sinorphan on plasma atrial natriuretic factor in congestive heart failure
32. Role of duration of diuretic effect in preventing sodium retention
33. Renal response to candoxatrilat in patients with heart failure
34. Changes in indocyanine green kinetics after the administration of enalapril to healthy subjects
35. Capillary hydraulic conductivity is elevated by cGMP-dependent vasodilators
36. Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure
37. Atrial natriuretic peptide levels in heart failure in man before and during converting enzyme inhibition
38. Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11
39. Effect of atrial natriuretic peptide on muscle sympathetic activity and its reflex control in human heart failure
40. Atrial natriuretic factor attenuates sympathetic reflexes during lower body negative pressure in normal men